Working… Menu

Cisplatin and Gemcitabine Hydrochloride With or Without Berzosertib in Treating Patients With Metastatic Urothelial Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02567409
Recruitment Status : Active, not recruiting
First Posted : October 5, 2015
Last Update Posted : September 17, 2021
Information provided by (Responsible Party):
National Cancer Institute (NCI)